Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRB2 | P07550 | 1/20 | 0.50 |
| ▸ | PRCP | P42785 | 5/20 | 0.38 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.37 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | HPGD | P15428 | 1/20 | 0.35 |
| ▸ | FBP1 | P09467 | 2/20 | 0.35 |
| ▸ | BRD4 | O60885 | 1/20 | 0.35 |
| ▸ | FFAR2 | O15552 | 1/20 | 0.35 |
| ▸ | IDO1 | P14902 | 1/20 | 0.34 |
| ▸ | TDO2 | P48775 | 1/20 | 0.34 |
| ▸ | GABBR2 | O75899 | 1/20 | 0.34 |
| ▸ | GABBR1 | Q9UBS5 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | DPP4 | P27487 | 1/20 | 0.33 |
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL264810 | 0.76 | ADRB2 (0.46) | ADRB2SLC6A2SLC6A3ALDH1A1MAPT | |
| SCHEMBL1123827 | 0.73 | BRD4 (0.46) | ADRB2SLC6A2SLC6A3ALDH1A1MAPT | |
| SCHEMBL11949354 | 0.72 | ADRB2 (0.62) | ADRB2PRCPSLC6A2SLC6A3HPGD | |
| SCHEMBL27339647 | 0.70 | ADRB2 (0.41) | ADRB2SLC6A2SLC6A3ALDH1A1MAPT | |
| SCHEMBL115819 | 0.69 | ALDH1A1 (0.40) | ADRB2SLC6A2SLC6A3ALDH1A1MAPT | |
| SCHEMBL22559530 | 0.68 | FBP1 (0.39) | ADRB2ALDH1A1MAPTHPGDFBP1 | |
| SCHEMBL16687360 | 0.68 | ADRB2 (0.56) | ADRB2PRCPSLC6A2SLC6A3HPGD | |
| SCHEMBL19577176 | 0.68 | ADRB2 (0.56) | ADRB2PRCPSLC6A2SLC6A3HPGD | |
| SCHEMBL177057 | 0.68 | ADRB2 (1.00) | ADRB2SLC6A2SLC6A3HPGDBRD4 | |
| SCHEMBL436846 | 0.68 | ADRB2 (0.56) | ADRB2PRCPSLC6A2SLC6A3HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2005037215-A2 | COMPOSITIONS AND METHODS FOR ENHANCING COGNITIVE FUNCTION AND SYNAPTIC PLASTICITY | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2005-04-28 | — | — | WO | claimed |
| WO-2012054816-A2 | METHODS OF DELAYING AND TREATING DIABETES | MITOKINE BIOSCIENCE, LLC (US) | 2012-04-26 | — | — | WO | disclosed |
| WO-2009121496-A2 | USE OF A BIOLOGICALLY ACTIVE BLOOD SERUM FOR THE TREATMENT OF A DISORDER CHARCTERIZED IN A REDUCED FUNCTION OF A GABA RECEPTOR | OWEN HOLDING LTD. (GB) | 2009-10-08 | — | — | WO | disclosed |
| EP-1729740-A2 | PHARMACEUTICAL DOSAGE FORMS HAVING IMMEDIATE RELEASE AND/OR CONTROLLED RELEASE PROPERTIES THAT CONTAIN A GABA<SB>B</SB> RECEPTOR AGONIST | Impax Laboratories, Inc. (US) | 2006-12-13 | — | — | EP | disclosed |
| US-20060241134-A1 | Pharmaceutical combinations of a proton pump inhibitor and a compound which modifies gastrointestinal motility | ALTANA PHARMA GA (DE) | 2006-10-26 | — | — | US | disclosed |
| EP-1401423-A4 | METHOD OF TREATING GASTROESOPHAGEAL REFLUX DISEASE AND NOCTURNAL ACID BREAKTHROUGH | DEPOMED DEV LTD (BM) | 2006-08-16 | — | — | EP | disclosed |
| WO-2005097079-A2 | CONTROLLED RELEASE DOSAGE FOR GABA RECEPTOR AGONIST | IMPAX LABORATORIES, INC. (US) | 2005-10-20 | — | — | WO | disclosed |
| WO-2005037215-A2 | COMPOSITIONS AND METHODS FOR ENHANCING COGNITIVE FUNCTION AND SYNAPTIC PLASTICITY | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2005-04-28 | — | — | WO | disclosed |
| EP-1401423-A1 | METHOD OF TREATING GASTROESOPHAGEAL REFLUX DISEASE AND NOCTURNAL ACID BREAKTHROUGH | Depomed Development, Ltd (GB) | 2004-03-31 | — | — | EP | disclosed |
| WO-2002096404-A1 | METHOD OF TREATING GASTROESOPHAGEAL REFLUX DISEASE AND NOCTURNAL ACID BREAKTHROUGH | DEPOMED DEVELOPMENT LTD (GB) | 2002-12-05 | — | — | WO | disclosed |